China Biotech Services Holdings Limited (8037.HK)

HKD 0.4

(0.0%)

Gross Profit Summary of China Biotech Services Holdings Limited

  • China Biotech Services Holdings Limited's latest annual gross profit in 2023 was 34.32 Million HKD , down -96.88% from previous year.
  • China Biotech Services Holdings Limited's latest quarterly gross profit in 2024 Q2 was -1.55 Million HKD , down 0.0% from previous quarter.
  • China Biotech Services Holdings Limited reported a annual gross profit of 1.1 Billion HKD in annual gross profit 2022, up 207.51% from previous year.
  • China Biotech Services Holdings Limited reported a annual gross profit of 358.02 Million HKD in annual gross profit 2021, up 5.59% from previous year.
  • China Biotech Services Holdings Limited reported a quarterly gross profit of -1.55 Million HKD for 2024 Q1, up 94.25% from previous quarter.
  • China Biotech Services Holdings Limited reported a quarterly gross profit of 12.16 Million HKD for 2023 Q2, down -75.25% from previous quarter.

Annual Gross Profit Chart of China Biotech Services Holdings Limited (2023 - 2005)

Historical Annual Gross Profit of China Biotech Services Holdings Limited (2023 - 2005)

Year Gross Profit Gross Profit Growth
2023 34.32 Million HKD -96.88%
2022 1.1 Billion HKD 207.51%
2021 358.02 Million HKD 5.59%
2020 339.08 Million HKD 1415.59%
2019 22.37 Million HKD -20.34%
2018 28.08 Million HKD -7.01%
2017 30.2 Million HKD 0.53%
2016 30.04 Million HKD 211.97%
2015 9.63 Million HKD -81.81%
2014 52.93 Million HKD 47.57%
2013 35.87 Million HKD -21.33%
2012 45.6 Million HKD 1071.33%
2011 3.89 Million HKD -90.38%
2010 40.48 Million HKD -54.45%
2009 88.88 Million HKD -44.64%
2008 160.55 Million HKD -7.04%
2007 172.71 Million HKD 18.66%
2006 145.56 Million HKD 14.3%
2005 127.34 Million HKD 0.0%

Peer Gross Profit Comparison of China Biotech Services Holdings Limited

Name Gross Profit Gross Profit Difference
Life Healthcare Group Limited 37.78 Million HKD 9.169%